Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
mstdn.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
A general-purpose Mastodon server with a 500 character limit. All languages are welcome.

Administered by:

Server stats:

13K
active users

mstdn.social: AboutStatusProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.8

#PatentPools

0 posts0 participants0 posts today
Matthew Rimmer<p>'The World Health Organization (WHO) and Medicines Patent Pool (MPP) have... announced a sublicensing agreement between MPP and a Nigerian health technology company – Codix Bio – to start development and manufacturing of rapid diagnostic tests (RDTs) using technology transferred from global in-vitro diagnostics company – SD Biosensor (SDB). This agreement will contribute to advancing equitable access to vital diagnostic tools through local production, expanding manufacturing capacity in the African Region.' <a href="https://www.who.int/news/item/09-05-2025-who-and-medicines-patent-pool-announce-sublicensing-agreement-for-rapid-diagnostic-test-technology" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">who.int/news/item/09-05-2025-w</span><span class="invisible">ho-and-medicines-patent-pool-announce-sublicensing-agreement-for-rapid-diagnostic-test-technology</span></a> <a href="https://aus.social/tags/patent" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patent</span></a> <a href="https://aus.social/tags/patentpools" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>patentpools</span></a> <a href="https://aus.social/tags/access2meds" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>access2meds</span></a></p>
Kevin Karhan :verified:<p><span class="h-card" translate="no"><a href="https://mastodon.gamedev.place/@planettimmy" class="u-url mention">@<span>planettimmy</span></a></span> <span class="h-card" translate="no"><a href="https://peoplemaking.games/@glassbottommeg" class="u-url mention">@<span>glassbottommeg</span></a></span> <a href="https://mstdn.social/tags/H265" class="mention hashtag" rel="tag">#<span>H265</span></a> / <a href="https://mstdn.social/tags/AVC" class="mention hashtag" rel="tag">#<span>AVC</span></a> is contested by two <a href="https://mstdn.social/tags/PatentPools" class="mention hashtag" rel="tag">#<span>PatentPools</span></a> (so it&#39;s not like with <a href="https://mstdn.social/tags/H264" class="mention hashtag" rel="tag">#<span>H264</span></a> / <a href="https://mstdn.social/tags/MPEG4" class="mention hashtag" rel="tag">#<span>MPEG4</span></a> that you just pay <a href="https://mstdn.social/tags/MPEG" class="mention hashtag" rel="tag">#<span>MPEG</span></a> LA a fee)...</p><p><a href="https://mstdn.social/tags/AV1" class="mention hashtag" rel="tag">#<span>AV1</span></a> (<a href="https://mstdn.social/tags/VP9" class="mention hashtag" rel="tag">#<span>VP9</span></a> + <a href="https://mstdn.social/tags/Opus" class="mention hashtag" rel="tag">#<span>Opus</span></a>) &amp; <a href="https://mstdn.social/tags/WebM" class="mention hashtag" rel="tag">#<span>WebM</span></a> (<a href="https://mstdn.social/tags/VP8" class="mention hashtag" rel="tag">#<span>VP8</span></a> + <a href="https://mstdn.social/tags/Vorbis" class="mention hashtag" rel="tag">#<span>Vorbis</span></a>) are the way to go...<br /><a href="https://mstdn.social/@kkarhan/110470250159277923" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://</span><span class="ellipsis">mstdn.social/@kkarhan/11047025</span><span class="invisible">0159277923</span></a></p>
ExploreLive feeds
About